Skip to main content
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1991 Mar 15;88(6):2046–2050. doi: 10.1073/pnas.88.6.2046

Design, synthesis, and functional expression of a gene for charybdotoxin, a peptide blocker of K+ channels.

C S Park 1, S F Hausdorff 1, C Miller 1
PMCID: PMC51165  PMID: 1706515

Abstract

A gene encoding charybdotoxin (CTX), a K+ channel blocker from scorpion venom, was designed, synthesized, and expressed as a cleavable fusion protein in Escherichia coli. A sequence-specific protease, factor Xa, was used to cleave the fusion protein and thus release the toxin peptide. The recombinant toxin was purified, oxidized to form disulfide bonds, and treated to form N-terminal pyroglutamate. Recombinant CTX is identical to the native venom CTX with respect to high-performance liquid chromatography mobility, amino acid composition, and N-terminal modification. With single Ca2(+)-activated K+ channels as an assay system, recombinant CTX shows blocking and dissociation kinetics identical to the native venom toxin. The synthetic gene and high-level expression of functionally active CTX make it possible to study the fundamental mechanism of the toxin-ion channel interaction.

Full text

PDF
2048

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson C. S., MacKinnon R., Smith C., Miller C. Charybdotoxin block of single Ca2+-activated K+ channels. Effects of channel gating, voltage, and ionic strength. J Gen Physiol. 1988 Mar;91(3):317–333. doi: 10.1085/jgp.91.3.317. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Castle N. A., Strong P. N. Identification of two toxins from scorpion (Leiurus quinquestriatus) venom which block distinct classes of calcium-activated potassium channel. FEBS Lett. 1986 Dec 1;209(1):117–121. doi: 10.1016/0014-5793(86)81095-x. [DOI] [PubMed] [Google Scholar]
  3. Gimenez-Gallego G., Navia M. A., Reuben J. P., Katz G. M., Kaczorowski G. J., Garcia M. L. Purification, sequence, and model structure of charybdotoxin, a potent selective inhibitor of calcium-activated potassium channels. Proc Natl Acad Sci U S A. 1988 May;85(10):3329–3333. doi: 10.1073/pnas.85.10.3329. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Guggino S. E., Guggino W. B., Green N., Sacktor B. Blocking agents of Ca2+-activated K+ channels in cultured medullary thick ascending limb cells. Am J Physiol. 1987 Feb;252(2 Pt 1):C128–C137. doi: 10.1152/ajpcell.1987.252.2.C128. [DOI] [PubMed] [Google Scholar]
  5. Hermann A., Erxleben C. Charybdotoxin selectively blocks small Ca-activated K channels in Aplysia neurons. J Gen Physiol. 1987 Jul;90(1):27–47. doi: 10.1085/jgp.90.1.27. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Howell M. L., Blumenthal K. M. Cloning and expression of a synthetic gene for Cerebratulus lacteus neurotoxin B-IV. J Biol Chem. 1989 Sep 15;264(26):15268–15273. [PubMed] [Google Scholar]
  7. MacKinnon R., Heginbotham L., Abramson T. Mapping the receptor site for charybdotoxin, a pore-blocking potassium channel inhibitor. Neuron. 1990 Dec;5(6):767–771. doi: 10.1016/0896-6273(90)90335-d. [DOI] [PubMed] [Google Scholar]
  8. MacKinnon R., Miller C. Functional modification of a Ca2+-activated K+ channel by trimethyloxonium. Biochemistry. 1989 Oct 3;28(20):8087–8092. doi: 10.1021/bi00446a019. [DOI] [PubMed] [Google Scholar]
  9. MacKinnon R., Miller C. Mechanism of charybdotoxin block of the high-conductance, Ca2+-activated K+ channel. J Gen Physiol. 1988 Mar;91(3):335–349. doi: 10.1085/jgp.91.3.335. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. MacKinnon R., Miller C. Mutant potassium channels with altered binding of charybdotoxin, a pore-blocking peptide inhibitor. Science. 1989 Sep 22;245(4924):1382–1385. doi: 10.1126/science.2476850. [DOI] [PubMed] [Google Scholar]
  11. MacKinnon R., Reinhart P. H., White M. M. Charybdotoxin block of Shaker K+ channels suggests that different types of K+ channels share common structural features. Neuron. 1988 Dec;1(10):997–1001. doi: 10.1016/0896-6273(88)90156-0. [DOI] [PubMed] [Google Scholar]
  12. MacKinnon R., Yellen G. Mutations affecting TEA blockade and ion permeation in voltage-activated K+ channels. Science. 1990 Oct 12;250(4978):276–279. doi: 10.1126/science.2218530. [DOI] [PubMed] [Google Scholar]
  13. Massefski W., Jr, Redfield A. G., Hare D. R., Miller C. Molecular structure of charybdotoxin, a pore-directed inhibitor of potassium ion channels. Science. 1990 Aug 3;249(4968):521–524. doi: 10.1126/science.1696395. [DOI] [PubMed] [Google Scholar]
  14. Miller C. Competition for block of a Ca2(+)-activated K+ channel by charybdotoxin and tetraethylammonium. Neuron. 1988 Dec;1(10):1003–1006. doi: 10.1016/0896-6273(88)90157-2. [DOI] [PubMed] [Google Scholar]
  15. Miller C., Moczydlowski E., Latorre R., Phillips M. Charybdotoxin, a protein inhibitor of single Ca2+-activated K+ channels from mammalian skeletal muscle. Nature. 1985 Jan 24;313(6000):316–318. doi: 10.1038/313316a0. [DOI] [PubMed] [Google Scholar]
  16. Oprian D. D., Molday R. S., Kaufman R. J., Khorana H. G. Expression of a synthetic bovine rhodopsin gene in monkey kidney cells. Proc Natl Acad Sci U S A. 1987 Dec;84(24):8874–8878. doi: 10.1073/pnas.84.24.8874. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Reinhart P. H., Chung S., Levitan I. B. A family of calcium-dependent potassium channels from rat brain. Neuron. 1989 Jan;2(1):1031–1041. doi: 10.1016/0896-6273(89)90227-4. [DOI] [PubMed] [Google Scholar]
  18. Sands S. B., Lewis R. S., Cahalan M. D. Charybdotoxin blocks voltage-gated K+ channels in human and murine T lymphocytes. J Gen Physiol. 1989 Jun;93(6):1061–1074. doi: 10.1085/jgp.93.6.1061. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Schneider M. J., Rogowski R. S., Krueger B. K., Blaustein M. P. Charybdotoxin blocks both Ca-activated K channels and Ca-independent voltage-gated K channels in rat brain synaptosomes. FEBS Lett. 1989 Jul 3;250(2):433–436. doi: 10.1016/0014-5793(89)80771-9. [DOI] [PubMed] [Google Scholar]
  20. Schweitz H., Stansfeld C. E., Bidard J. N., Fagni L., Maes P., Lazdunski M. Charybdotoxin blocks dendrotoxin-sensitive voltage-activated K+ channels. FEBS Lett. 1989 Jul 3;250(2):519–522. doi: 10.1016/0014-5793(89)80788-4. [DOI] [PubMed] [Google Scholar]
  21. Smith C., Phillips M., Miller C. Purification of charybdotoxin, a specific inhibitor of the high-conductance Ca2+-activated K+ channel. J Biol Chem. 1986 Nov 5;261(31):14607–14613. [PubMed] [Google Scholar]
  22. Studier F. W., Moffatt B. A. Use of bacteriophage T7 RNA polymerase to direct selective high-level expression of cloned genes. J Mol Biol. 1986 May 5;189(1):113–130. doi: 10.1016/0022-2836(86)90385-2. [DOI] [PubMed] [Google Scholar]
  23. Stühmer W., Ruppersberg J. P., Schröter K. H., Sakmann B., Stocker M., Giese K. P., Perschke A., Baumann A., Pongs O. Molecular basis of functional diversity of voltage-gated potassium channels in mammalian brain. EMBO J. 1989 Nov;8(11):3235–3244. doi: 10.1002/j.1460-2075.1989.tb08483.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Wolff D., Cecchi X., Spalvins A., Canessa M. Charybdotoxin blocks with high affinity the Ca-activated K+ channel of Hb A and Hb S red cells: individual differences in the number of channels. J Membr Biol. 1988 Dec;106(3):243–252. doi: 10.1007/BF01872162. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES